Professional Documents
Culture Documents
Personal History
He is non-smoker, no history of IV drug abuse, no history of exposure.
Family History
He is married and has a son.
He has family history of hepatitis B infection.His mother & two brother
were suffering from liver cirrohosis due to chronic hepatitis B infection
& had died most likely of liver cirrhosis.
Drug history
He was on Tab.Entecavir (0.5mg) since 2021.
Allergic history
He had no history of allergic reaction to any foods or known drugs.
Immunization History
He is immunized according to current EPI schedule and also vaccinated
for COVID-19.
Auscultation:
Normal, bowel sound is present.
• total score =5
• Child Class: A
Surgical plan
• Right Lobectomy
Pre operative Management
• Patient was counseled about his disease, treatment protocol &
prognosis.
• Improvement of nutritional status with maximum protein
supplementation tolerable by the patient.
• To ensure hepatic glycogen is maximal, patient received an
intravenous glucose load (1L of 10% dextrose) prior to surgery.
• Informed written consent was taken from the legal guardian.
Operation Note
• Date: 30/09/23
• Time: 11:30AM-03:30PM
• Venue: GOT, SSMCMH
• Name of indication: Hepatocellular Carcinoma due to
Chronic Hepatitis B
• Name of operation: Non anatomical resection of Hepatic
segment V, VI & partially VII
Contd...
• Surgical approach : Open
• Incision: Modified Makuuchi
Laparatomy Findings:
• Hard irregular 3×3 cm intraparenchymal
mass was found involving hepatic
segment V,VI and partially VII.
• Rest of liver parenchyma was cirrhotic.
Surgical Procedure
• Assesment of locoregional & distant metastasis & operability.
• Caudally dissection of right triangular ligament & then coronary
ligament.
• Mobilisation of Right Lobe was done
• Inflow was controlled by Pringle’s manoeuvre.
• Cholecystectomy was done.
• Wide local free margin of tumor selected & resected by crush and
clump technique.
[continued]
• Haemostasis & control of
bleeding was done with
Prolene 3-0 RB.
• Resected bed was embedded
with spongstat.
• After keeping 20Fr Drain tube
at Hepatorenal pouch,wound
was closed by No.1 PDS loop.
• Skin was closed by Stapler.
Histopathology of the specimen
Gross description:
Slicing of liver specimen reveals a 3.0x2.7x2.5 cm well circumscribe
tumour. It is 0.3 cm away from the capsule and 1.5 cm away from the
nearest resection margins. It also reveal multinodularity in its outer
surface.Sections of liver tumor reveal-
An well differentiated hepatocellular carcinoma.
• Capsular invasion is present.
• Lymphovascular invasion is present.
• Perineural invasion is not seen.
• The surgical resection margin is free.
Histopathology of the specimen
Sections of gallbladder wall reveal moderate infiltration of
inflammatory cells and mild fibrosis.
Diagnosis-
1. Liver SOL: Hepatocellular carcinoma,well differentiated in the
background of cirrhosis.
2. Gallbladder: Free of tumor.
Post operative period
• His post operative period was uneventful.
• He was allowed sips of water on 4 th POD & liquid diet on 5th POD.
• Drain Collection was approx. 400-500ml /24hour upto 5th POD, then
gradually deceased to nil.
• On 22th POD drain tube was off & all stitches were off.
• After consulting with Oncology department, he was advised to take
Tab. Sorafenib as adjuvant chemotherapy & got discharged on
27/10/23 with advice to follow up after 4 weeks .
Follow-Up:
• Patient was followed up after 1 month post operatively on 20/11/23
when liver function test, AFP which was within normal limit.
• Next follow up was planned after 1 month
Any Questions
Hepatocellular Carcinoma
• HCC is the fifth most common malignancy worldwide, with an
estimated 750,000 new cases diagnosed annually.
• Because of its high fatality, it is the third most common cause of
cancer death worldwide.
• Major risk factors are-
• Viral hepatitis (B or C),
• Alcoholic cirrhosis
• Hemochromatosis
• NASH
Continued..
• Although cirrhosis is not present in all cases, it has been estimated to
be present 70% to 90% of the time.
• In a person with cirrhosis, the annual conversion rate to HCC is 2% to
6%.
• In patients with chronic HCV infection, cirrhosis is usually present
before the HCC develops.
• However, in cases of hepatitis B virus infection, HCC tumors can occur
before the onset of cirrhosis.
Clinical features of HCC
• HCC exhibits a male dominance with an average sex ratio of 3:1
• In early stage, HCC in asymptomatic and is only discovered by
screening (ultrasound, AFP) in individuals at risk of the disease
In symptomatic disease,